Sign In
Buy CODX
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Why Co-Diagnostics Trounced the Market on Thursday
06:01pm, Thursday, 26'th May 2022
The company is not monkeying around with the latest possible global health menace.
Co-Diagnostics develops principal design work on monkeypox PCR test
10:54am, Thursday, 26'th May 2022
Co-Diagnostics (NASDAQ:CODX) Inc, a molecular diagnostics company, has completed the principal design work on a PCR test for the monkeypox virus, the company announced. Outbreaks of the virus have b
10 Biggest Price Target Changes For Monday
11:53am, Monday, 16'th May 2022 Benzinga
Needham cut the price target on Carvana Co. (NYSE: CVNA) from $121 to $80. Carvana shares rose 11.3% to $42.71 in pre-market trading.
Susquehanna cut Taboola.com Ltd. (NASDAQ: TBLA) price target f
Co-Diagnostics Stock Surges As Q1 Results Surpass Street Expectations
11:09pm, Thursday, 12'th May 2022 Benzinga
Co-Diagnostics Inc (NASDAQ: CODX) reported first-quarter revenue growth of 13.4% year-over-year to $22.7 million, beating the consensus of $20.17 million.
The increase in revenue is attributable to th
CoDiagnostics, Inc. (CODX) Q1 Earnings and Revenues Beat Estimates
09:25pm, Thursday, 12'th May 2022 Zacks Investment Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 44.44% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q1 2022 Results - Earnings Call Transcript
08:08pm, Thursday, 12'th May 2022
Co-Diagnostics, Inc. (NASDAQ:CODX ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Andrew Benson - Head, IR Dwight Egan - Chairman, CEO & President Brian Brown - CFO & C
CoDiagnostics, Inc. (CODX) Q1 Earnings and Revenues Beat Estimates
06:48pm, Thursday, 12'th May 2022
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 44.44% and 6.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics reports record 1Q revenue as company looks to expand into new markets and innovative molecular diagnostics solutions
04:46pm, Thursday, 12'th May 2022
Co-Diagnostics (NASDAQ:CODX) Inc has reported record 1Q revenue as the company says it plans to leverage its strong financial position to fund future growth initiatives. For the quarter ending March 3
CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
09:30am, Thursday, 28'th Apr 2022
SALT LAKE CITY , April 28, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Why the Earnings Surprise Streak Could Continue for CoDiagnostics, Inc. (CODX)
01:32pm, Tuesday, 26'th Apr 2022
CoDiagnostics, Inc. (CODX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Co-Diagnostics (NASDAQ:CODX) has said that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization
Why Co-Diagnostics Stock Tumbled by Nearly 12% Today
11:03pm, Friday, 25'th Mar 2022 The Motley Fool
The company released its 2021 earnings, and investors weren't happy with them despite profitability guidance that beat estimates.
Why Co-Diagnostics Stock Tumbled by Nearly 12% Today
07:03pm, Friday, 25'th Mar 2022
The company released its 2021 earnings, and investors weren't happy with them despite profitability guidance that beat estimates.
CoDiagnostics, Inc. (CODX) Q4 Earnings Beat Estimates
11:05pm, Thursday, 24'th Mar 2022 Zacks Investment Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 66.67% and 5.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics, Inc. (CODX) Q4 Earnings Beat Estimates
08:19pm, Thursday, 24'th Mar 2022
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 66.67% and 5.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
